Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2019-12-04 10:36:47]
5 Years H
1
Impact Factor
0.06
5 Years IF
0.06
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.1 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.11 0 0 0 0 0 0 0 0 0 0 0.05
1995 0 0.19 0 0 0 0 0 0 0 0 0 0 0.08
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.1
1997 0 0.22 0 0 0 0 0 0 0 0 0 0 0.09
1998 0 0.26 0 0 0 0 0 0 0 0 0 0 0.12
1999 0 0.28 0 0 0 0 0 0 0 0 0 0 0.14
2000 0 0.33 0 0 0 0 0 0 0 0 0 0 0.15
2001 0 0.36 0 0 0 0 0 0 0 0 0 0 0.15
2002 0 0.39 0 0 0 0 0 0 0 0 0 0 0.21
2003 0 0.4 0 0 0 0 0 0 0 0 0 0 0.2
2004 0 0.45 0 0 0 0 0 0 0 0 0 0 0.2
2005 0 0.46 0 0 0 0 0 0 0 0 0 0 0.22
2006 0 0.46 0 0 0 0 0 0 0 0 0 0 0.21
2007 0 0.42 0 0 0 0 0 0 0 0 0 0 0.18
2008 0 0.44 0 0 0 0 0 0 0 0 0 0 0.21
2009 0 0.44 0 0 0 0 0 0 0 0 0 0 0.21
2010 0 0.43 0 0 0 0 0 0 0 0 0 0 0.18
2011 0 0.46 0 0 0 0 0 0 0 0 0 0 0.21
2012 0 0.47 0 0 0 0 0 0 0 0 0 0 0.19
2013 0 0.53 0 0 0 0 0 0 0 0 0 0 0.22
2014 0 0.55 0 0 0 0 0 0 0 0 0 0 0.22
2015 0 0.56 0 0 0 0 0 0 0 0 0 0 0.21
2016 0 0.58 0 0 0 0 0 0 0 0 0 0 0.2
2017 0 0.6 0.06 0 31 31 5 2 2 0 0 1 50 2 0.06 0.22
2018 0.06 0.76 0.05 0.06 43 74 3 4 6 31 2 31 2 1 25 2 0.05 0.31
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12017Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Vogler, Sabine ; Paterson, Kenneth R. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1.

Full description at Econpapers || Download paper

2
22018The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5.

Full description at Econpapers || Download paper

1
32017Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2.

Full description at Econpapers || Download paper

1
42018Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Regmi, Kabindra ; Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4.

Full description at Econpapers || Download paper

1
52017Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”. (2017). Holko, Przemysaw . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0008-x.

Full description at Econpapers || Download paper

1
62017Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Round, Jeff ; Hawton, Annie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2.

Full description at Econpapers || Download paper

1
72018Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary. (2018). Nord, Erik ; Lamoy, Christoffer. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-018-0079-y.

Full description at Econpapers || Download paper

1
82018Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?. (2018). Garattini, Livio ; Padula, Anna. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-018-0069-0.

Full description at Econpapers || Download paper

1
92017Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. (2017). Kolovos, Spyros ; Tulder, Maurits W ; Chevreul, Karine ; Riper, Heleen ; Bosmans, Judith E. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0014-7.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12017Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Vogler, Sabine ; Paterson, Kenneth R. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 2
YearTitle
2018Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist. (2018). Holko, Przemysaw ; Pilc, Andrzej ; Kawalec, Pawe. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0653-2.

Full description at Econpapers || Download paper

2018Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods. (2018). Crott, Ralph . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0049-9.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2018

YearCiting document
2018Delving into the Impact of Job Match and Remuneration on Burnout and Turnover Intention among Pharmacists in Pakistan. (2018). Matloob, Sheema ; Sikander, Raja ; Halim, Hasliza Abdul ; Bhatti, Zohra. In: International Journal of Academic Research in Business and Social Sciences. RePEc:hur:ijarbs:v:8:y:2018:i:6:p:898-911.

Full description at Econpapers || Download paper

2018EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. (2018). Kaltenthaler, Eva ; Dickson, Rumona ; Buyukkaramikli, Nasuh ; Joore, Manuela ; Ramaekers, Bram ; Brazzelli, Miriam ; Grimm, Sabine ; Armoiry, Xavier ; Riemsma, Rob ; Shepherd, Jonathan ; Hodgson, Robert ; Hoyle, Martin ; Woolacott, Nerys ; Edwards, Steve ; Kotas, Eleanor ; Pandor, Abdullah ; Duarte, Rui ; Stevenson, Matt ; Boland, Angela. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:4:d:10.1007_s40258-018-0393-7.

Full description at Econpapers || Download

Recent citations received in 2017

YearCiting document
2017Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2.

Full description at Econpapers || Download paper

2017Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2.

Full description at Econpapers || Download paper